pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›calendar
  3. ›recall
recall
save

Denver Solutions, LLC DBA Leiters Health recall (Cls II)

April 30, 2025updated 5mo ago
community read0 votes

Rocuronium Bromide 50 mg per 5mL (10mg per mL), 5mL Single Dose Syringe, Rx only, Leiters Health, 13796 Compark Blvd, Englewood, CO 80112. NDC: 71449-004-11 — Reason: Lack of Assurance of Sterility: Leaking/damaged syringes. — Status: Ongoing

view source ↗
Data sources
fda recalls
last refreshed 9m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

same company · ±60 days · 6

  • recallDenver Solutions, LLC DBA Leiters Health recall (Cls II)Apr 30, 2025
  • approvalOTULFI: OTULFI (USTEKINUMAB-AAUZ) — FDA approvalApr 30, 2025
  • approvalOTULFI: OTULFI (USTEKINUMAB-AAUZ) — FDA approvalApr 30, 2025
  • approvalTYENNE: TYENNE (TOCILIZUMAB-AAZG) — FDA approvalMay 12, 2025
  • approvalOTULFI: OTULFI (USTEKINUMAB-AAUZ) — FDA approvalApr 14, 2025
  • approvalSTIMUFEND: STIMUFEND (PEGFILGRASTIM-FPGK) — FDA approvalMar 26, 2025

🐶 often sniffed alongside

top 8
  • tagApproval258 co-mentions · 129 sources
  • drugRNS-60236 co-mentions · 149 sources
  • drugDIPRIVAN78 co-mentions · 39 sources
  • drugPROPOFOL39 co-mentions · 39 sources
  • drugDILAUDID-HP38 co-mentions · 19 sources
  • tagRecall33 co-mentions · 20 sources
  • drughydromorphone hydrochloride ER19 co-mentions · 19 sources
  • drugHYDROMORPHONE HYDROCHLORIDE19 co-mentions · 19 sources

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?